Ethnic Disparities Exist in Cost of Care Before and After an Epilepsy Event
Compared with other races/ethnic groups, black Medicare beneficiaries have higher costs following an epilepsy event.
All articles by Brandon May
Peer Victimization May Predict Mood, Pain in Adolescents With Chronic Pain
Peer victimization may negatively affect mood and pain and may limit activity in youths with chronic pain.
Directly Observed Therapy Effective for Treatment-Resistant Hypertension
Regular assessment of adherence to blood pressure-lowering drugs as well as directly observed therapy may be helpful for resolving treatment-resistant hypertension.
Lack of Confidence in Undertaking Skin Self-Examinations in Patients With Melanoma
Efforts to integrate new digital technologies to increase regular and thorough skin self-examination for patients with melanoma are warranted, provided sufficient technical support is provided.
Synopsis of the Updated AHA/ACC Guideline for ASCVD Risk Reduction
The AHA/ACC published a new clinical practice guideline on managing cholesterol and provided a risk assessment report on primary prevention of ASCVD.
Risk Prediction Tool Estimates 10-Year, Lifetime Risk for CVD in Healthy People
The LIFEtime-perspective CardioVascular Disease model can accurately estimate individual-level prognosis and treatment-effects in terms of improved 10-year risk, lifetime risk, and life-expectancy free of cardiovascular disease.
LDL and DLCNC Score May Identify Familial Hypercholesterolemia
A low-density lipoprotein-cholesterol level >4.9 mmol/L in addition to the Dutch Lipid Clinic Network Criteria score may help identify probable/definite or possible familial hypercholesterolemia.
Are Febrile Seizures Associated With Increased Sudden Death Risk in Young Children?
Recent data suggest that FS may contribute to sudden unexplained death in childhood.
Treatment Effect of Halobetasol Propionate/Tazarotene Combination Lotion for Plaque Psoriasis
A fixed-dose combination lotion comprised of halobetasol propionate 0.01% and tazarotene 0.045% (HP/TAZ) is more effective for treating moderate-to-severe plaque psoriasis than either component alone.
Next post in Dermatology Information Center
